Feature | March 26, 2013

SNMMI Launches Online Dose Optimization Resource

SNMMI Launches Online Dose Optimization Resource

March 26, 2013 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) launched a new online resource for imaging professionals, referring physicians and the public on dose optimization for nuclear medicine and molecular imaging procedures. The information is designed to help ensure patients receive the smallest possible amount of radiopharmaceutical that will provide the appropriate diagnostic information.

“Advancing a better understanding of radiation dose and risk and promoting dose optimization in nuclear medicine and molecular imaging is a top priority for SNMMI,” said Frederic H. Fahey, DSC, SNMMI president. “The online resource is a key component of our dose optimization initiative, as it compiles important information in an organized fashion in one central location.”

The online resource includes SNMMI journal articles, abstracts, educational offerings, news articles, presentations and links to useful websites, as well as other materials. The resource will be promoted to SNMMI members through various communication channels, promoted through social media and shared with referring physician and patient groups.

In June 2012, SNMMI started its dose optimization initiative by issuing a position statement, saying that radiation dose for all nuclear medicine and molecular imaging procedures should be optimized by ensuring that the patient receives the minimum radiation dose necessary to provide useful diagnostic information. The position statement recognizes that the use of low levels of radiation in nuclear medicine procedures carries some possible risk. However, if an appropriate procedure — one that can provide the physician with clinical information essential to the patient’s treatment — is not performed when necessary due to fear of radiation, it can be detrimental to the patient.

Dose optimization has become a part of SNMMI’s communications, outreach, advocacy and education efforts. This integrated approach helps to provide information and guidance on dose optimization to imaging professionals, referring physicians, policy makers and the public. In addition to these activities, SNMMI continues to actively participate in the Image Gently and Image Wisely campaigns. 

“It is our firm belief that the ‘right test with the right dose should be given to the right patient at the right time,’” said Fahey. “We hope that this online resource will provide professionals with tools they can use to implement this into clinical practice and educate the public about optimal dosing for nuclear medicine and molecular imaging procedures.”

For more information: www.snmmi.org/dose

Related Content

Guerbet Partners With Imalogix on Dose Optimization With Artificial Intelligence
News | Radiation Dose Management | August 14, 2018
August 14, 2018 — Guerbet LLC USA announced a commercial partnership with Imalogix, a provider of...
PET Tracer Identifies Estrogen Receptor Expression Differences in Breast Cancer Patients
News | PET Imaging | August 09, 2018
In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the...
Imalogix Brings Fluoroscopy Capabilities to Radiation Dose Management Platform
Technology | Radiographic Fluoroscopy (RF) | August 06, 2018
Imalogix, a provider of artificial intelligence (AI) process and workflow solutions, announced the availability of the...
Novel PET Imaging Method Could Track and Guide Type 1 Diabetes Therapy
News | PET Imaging | August 03, 2018
Researchers have discovered a new nuclear medicine test that could improve care of patients with type 1 diabetes. The...
Sectra radiation dose monitoring software can help manage radiation dose from multiple medical imaging modalities.
News | Radiation Dose Management | July 25, 2018
July 25, 2018 – Sectra will install its cloud-based,...
Researchers Trace Parkinson’s Damage in the Heart
News | PET Imaging | July 17, 2018
A new way to examine stress and inflammation in the heart will help Parkinson’s researchers test new therapies and...
Siemens Healthineers Announces FDA Clearance of syngo.via VB30 Molecular Imaging Software
Technology | Nuclear Imaging | July 16, 2018
At the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26 in Philadelphia...
The images (before and after) depict a 50 percent dose reduction in chest X-ray without compromising  image quality.

The images (before) depict a 50 percent dose reduction in chest X-ray without compromising
image quality.

Sponsored Content | Case Study | Radiation Dose Management | July 03, 2018
There are a handful of priorities for radiologists: lowest radiation dosage, highest image quality, optimal workflow,...
Overlay Init